BIOVENTRIX, INC.
Revivent, a minimally invasive cardiac device that uses direct ventricular restoration to treat heart failure
- Sector
- Medtech
- Headquarters
- MANSFIELD, MA
- Latest Form D
- $1.2M, Oct 2026
- Total capital
- $62.4M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $62.4M
- 26 Form D · last Oct 2026
- 1 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 38
- 2 pending · first 2016
- Rank in peer group#38 of 1112
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 25th filing$1.2M
- Private capital raisedForm D · SEC · 24th filing$705K
- Private capital raisedForm D · SEC · 23rd filing$125K
- Private capital raisedForm D · SEC · 22nd filing$2.4M
- Private capital raisedForm D · SEC · 21st filing$12.7M
- Private capital raisedForm D · SEC · 20th filing$2M
- Private capital raisedForm D · SEC · 19th filing$1M
- Private capital raisedForm D · SEC · 18th filing$6M
- Private capital raisedForm D · SEC · 17th filing$4.3M
- Private capital raisedForm D · SEC · 16th filing$1.3M
- Private capital raisedForm D · SEC · 15th filing$2.5M
- Private capital raisedForm D · SEC · 14th filing$1.3M
- Private capital raisedForm D · SEC · 13th filing$1.2M
- Private capital raisedForm D · SEC · 12th filing$2M
- Private capital raisedForm D · SEC · 11th filing$1.1M
- Private capital raisedForm D · SEC · 10th filing$1M
- Private capital raisedForm D · SEC · 9th filing$525K
- Private capital raisedForm D · SEC · 8th filing$767K
- Private capital raisedForm D · SEC · 7th filing$2.6M
- Private capital raisedForm D · SEC · 6th filing$330K
- Private capital raisedForm D · SEC · 5th filing$6M
- Private capital raisedForm D · SEC · 4th filing$5.1M
- Private capital raisedForm D · SEC · 3rd filing$5.1M
- Private capital raisedForm D · SEC · 2nd filing$936K
- Private capital raisedForm D · SEC · 1st filing$360K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
1 record has no date or no amount, so it isn’t placed on the timeline.
Standing among 1112 peers
Line = medianMedtech · Device
- Granted patents#38 · top 3%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- ANDREW COATSDirectorNamed in SEC Form D filings
- ANDREW HINSONDirectorNamed in SEC Form D filings
- BIHUA CHENDirectorNamed in SEC Form D filings
- CHRISTOPHER WOLFFExecutive OfficerNamed in SEC Form D filings
- DAVID RICHMONDExecutive Officer, DirectorNamed in SEC Form D filings
- GEORGE FAZIODirectorNamed in SEC Form D filings
Show all 27 people
- JAMES DILLONExecutive Officer, DirectorNamed in SEC Form D filings
- KENNETH MILLERExecutive Officer, DirectorNamed in SEC Form D filings
- LAUREN BAKERDirectorNamed in SEC Form D filings
- MARK RAVICHDirectorNamed in SEC Form D filings
- MICHAEL TAGLICHDirectorNamed in SEC Form D filings
- NOEL MESSENGERExecutive OfficerNamed in SEC Form D filings
- ORI BEN-YEHUDAExecutive OfficerNamed in SEC Form D filings
- Paul SeidDirectorNamed in SEC Form D filings
- RAPHAEL WISNIEWSKIDirectorNamed in SEC Form D filings
- RAYMOND COHENDirectorNamed in SEC Form D filings
- RINDA SAMADirectorNamed in SEC Form D filings
- RISHI PURIDirectorNamed in SEC Form D filings
- ROBERT TAGLICHDirectorNamed in SEC Form D filings
- STEPHEN HEALYDirectorNamed in SEC Form D filings
- STEVE CHARTIERExecutive OfficerNamed in SEC Form D filings
- STEVEN CHARTIERExecutive Officer, DirectorNamed in SEC Form D filings
- STEVEN HEALYDirectorNamed in SEC Form D filings
- THASEEGARAN PILLAY, M.D.Executive OfficerNamed in SEC Form D filings
- WARREN PINKERT IIDirectorNamed in SEC Form D filings
- WILLIAM ABBOTTExecutive OfficerNamed in SEC Form D filings
- WILLIAM ABRAHAMDirectorNamed in SEC Form D filings
What it has protected
USPTO · 38 granted of 40- PendingHeart Anchor Positioning Devices, Methods, And Systems For Treatment Of Congestive Heart Failure And Other ConditionsUSPTOApplication 19546191
- GrantedHeart Anchor Positioning Devices, Methods, And Systems For Treatment Of Congestive Heart Failure And Other ConditionsUSPTOUS 12,582,524
- GrantedTrans-catheter Ventricular Reconstruction Structures, Methods, And Systems For Treatment Of Congestive Heart Failure And Other ConditionsUSPTOUS 12,533,235
Show all 40 patent records
- Heart Anchor Positioning Devices, Methods, And Systems For Treatment Of Congestive Heart Failure And Other ConditionsJul 2, 2026 · Application 19546191Pending
- Heart Anchor Positioning Devices, Methods, And Systems For Treatment Of Congestive Heart Failure And Other ConditionsMar 24, 2026 · US 12,582,524Granted
- Trans-catheter Ventricular Reconstruction Structures, Methods, And Systems For Treatment Of Congestive Heart Failure And Other ConditionsJan 27, 2026 · US 12,533,235Granted
- Device And Methods For Monitoring Heart Function For Treatment Of Congestive Heart Failure And Other ConditionsJan 2, 2025 · Application 18701197Pending
- Heart Anchor Positioning Devices, Methods, And Systems For Treatment Of Congestive Heart Failure And Other ConditionsFeb 20, 2024 · US 11,903,834Granted
- Method And Apparatus For Closing Off A Portion Of A Heart VentricleOct 24, 2023 · US 11,793,643Granted
- Pericardial Inflation Catheter And Systems And Methods Employing SameSep 5, 2023 · US 11,744,615Granted
- Cardiac Tissue Penetrating Devices, Methods, And Systems For Treatment Of Congestive Heart Failure And Other ConditionsJan 24, 2023 · US 11,559,212Granted
- Cardiac Tissue Anchoring Devices, Methods, And Systems For Treatment Of Congestive Heart Failure And Other ConditionsJan 3, 2023 · US 11,540,822Granted
- Tissue Protecting Devices For Treatment Of Congestive Heart Failure And Other ConditionsDec 20, 2022 · US 11,529,234Granted
- Percutaneous Arterial Access To Position Trans-myocardial Implant Devices And MethodsOct 25, 2022 · US 11,478,353Granted
- Location, Time, And/or Pressure Determining Devices, Systems, And Methods For Deployment Of Lesion-excluding Heart Implants For Treatment Of Cardiac Heart Failure And Other Disease StatesAug 23, 2022 · US 11,419,723Granted
- Treating Dysfunctional Cardiac TissueAug 2, 2022 · US 11,399,942Granted
- Steerable Lesion Excluding Heart Implants For Congestive Heart FailureMay 17, 2022 · US 11,331,190Granted
- Method And Device For Percutaneous Left Ventricular ReconstructionMar 15, 2022 · US 11,273,040Granted
- Method And Device For Treating Dysfunctional Cardiac TissueMar 1, 2022 · US 11,259,929Granted
- Systems And Methods For Deploying A Cardiac AnchorNov 30, 2021 · US 11,185,414Granted
- Trans-catheter Ventricular Reconstruction Structures, Methods, And Systems For Treatment Of Congestive Heart Failure And Other ConditionsJul 6, 2021 · US 11,051,942Granted
- Over-the-wire Cardiac Implant Delivery System For Treatment Of Chf And Other ConditionsJul 6, 2021 · US 11,051,941Granted
- Treating Dysfunctional Cardiac TissueApr 21, 2020 · US 10,624,744Granted
- Method And Apparatus For Closing Off A Portion Of A Heart VentricleApr 21, 2020 · US 10,624,745Granted
- Tissue Protecting Devices For Treatment Of Congestive Heart Failure And Other ConditionsApr 14, 2020 · US 10,617,524Granted
- Location, Time, And/or Pressure Determining Devices, Systems, And Methods For Deployment Of Lesion-excluding Heart Implants For Treatment Of Cardiac Heart Failure And Other Disease StatesApr 14, 2020 · US 10,617,525Granted
- Cardiac Tissue Anchoring Devices, Methods, And Systems For Treatment Of Congestive Heart Failure And Other ConditionsMar 17, 2020 · US 10,588,613Granted
- Heart Anchor Positioning Devices, Methods, And Systems For Treatment Of Congestive Heart Failure And Other ConditionsMar 3, 2020 · US 10,575,953Granted
- Steerable Lesion Excluding Heart Implants For Congestive Heart FailureNov 19, 2019 · US 10,478,305Granted
- Method And Device For Percutaneous Left Ventricular ReconstructionSep 3, 2019 · US 10,398,557Granted
- Method And Device For Treating Dysfunctional Cardiac TissueJul 2, 2019 · US 10,335,279Granted
- Cardiac Tissue Penetrating Devices, Methods, And Systems For Treatment Of Congestive Heart Failure And Other ConditionsJun 11, 2019 · US 10,314,498Granted
- Cardiac Implant Migration Inhibiting SystemsMar 5, 2019 · US 10,219,904Granted
- Systems And Methods For Deploying A Cardiac AnchorFeb 19, 2019 · US 10,206,779Granted
- Trans-catheter Ventricular Reconstruction Structures, Methods, And Systems For Treatment Of Congestive Heart Failure And Other ConditionsJan 15, 2019 · US 10,179,049Granted
- Method And Apparatus For Closing Off A Portion Of A Heart VentricleJul 17, 2018 · US 10,022,226Granted
- Remote Pericardial Hemostasis For Ventricular Access And Reconstruction Or Other Organ TherapiesApr 10, 2018 · US 9,937,043Granted
- Location, Time, And/or Pressure Determining Devices, Systems, And Methods For Deployment Of Lesion-excluding Heart Implants For Treatment Of Cardiac Heart Failure And Other Disease StatesMar 13, 2018 · US 9,913,719Granted
- Treating Dysfunctional Cardiac TissueFeb 13, 2018 · US 9,889,008Granted
- Steerable Lesion Excluding Heart Implants For Congestive Heart FailureAug 29, 2017 · US 9,744,040Granted
- Trans-catheter Ventricular Reconstruction Structures, Methods, And Systems For Treatment Of Congestive Heart Failure And Other ConditionsMay 30, 2017 · US 9,662,212Granted
- Method And Device For Percutaneous Left Ventricular ReconstructionDec 27, 2016 · US 9,526,618Granted
- Treating Dysfunctional Cardiac TissueNov 8, 2016 · US 9,486,206Granted
Related companies, and why
- ORTHO HAUS LLCSimilar federal contract value in Medtech · null in contracts
- KYTARO, INC.Similar federal contract value in Medtech · null in contracts
- CONTEGO MEDICAL INCSimilar federal contract value in Medtech · null in contracts
- TOROMEDES, INC.Similar federal contract value in Medtech · null in contracts
- Digital Dental Solutions, Inc.Similar federal contract value in Medtech · null in contracts
- YorLabs, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .